Kazia Therapeutics Limited - stock earnings
KZIA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.4 million USD | 356 USD |
| 2023Q1 | -2.3 million USD | 186 USD |
| 2022Q4 | -9.3 million USD | ? USD |
| 2022Q3 | -7.7 million USD | -1.9 million USD |
| 2022Q2 | -4.7 million USD | ? USD |
| 2022Q1 | -4.4 million USD | ? USD |
| 2021Q4 | -9.6 million USD | 7264 USD |
| 2021Q3 | -1.5 million USD | 11.0 million USD |
| 2021Q2 | -1.0 million AUD | 7.6 million AUD |
| 2021Q1 | -781594 USD | 5.8 million USD |
| 2020Q4 | -4.9 million USD | 901 USD |
| 2020Q3 | -4.7 million USD | 259861 USD |
| 2020Q2 | 10.8 million USD | -6.8 million USD |
| 2020Q1 | -2.0 million USD | 111795 USD |
| 2019Q4 | -4.1 million USD | 438055 USD |
| 2019Q3 | -2.9 million USD | 455849 USD |
| 2019Q2 | -7.2 million USD | 10437 USD |
| 2019Q1 | -1.5 million USD | 237885 USD |
| 2018Q4 | -4.2 million USD | 541243 USD |
| 2018Q3 | -4.7 million USD | 1.1 million USD |
| 2018Q2 | -4.7 million USD | 38896 USD |
| 2018Q1 | -2.5 million USD | 597477 USD |
| 2017Q4 | 331160 USD | 1.1 million USD |
| 2017Q3 | -5.1 million USD | 3.3 million USD |
| 2017Q2 | -7.3 million USD | 6.9 million USD |
| 2017Q1 | -2.5 million USD | 1.6 million USD |
| 2016Q4 | -3.0 million USD | 3.3 million USD |
| 2016Q3 | -6.3 million USD | 180099 USD |
| 2016Q2 | -9.0 million USD | 2.4 million USD |
| 2016Q1 | -3.2 million USD | 90406 USD |
| 2015Q4 | -2.8 million USD | 2.2 million USD |
| 2015Q3 | -3.4 million USD | 90443 USD |
| 2015Q2 | -5.5 million USD | 1.3 million USD |
| 2015Q1 | -1.9 million USD | 49440 USD |
| 2014Q4 | -1.8 million USD | 1.3 million USD |
| 2014Q3 | -3.8 million USD | 348187 USD |
| 2014Q2 | -7.0 million USD | 403754 USD |
| 2014Q1 | -2.0 million USD | 184964 USD |
| 2013Q4 | -2.7 million USD | 26060 USD |
| 2013Q3 | -710160 USD | 236007 USD |
| 2013Q2 | ? USD | 349990 USD |
| 2013Q1 | -795388 USD | 258661 USD |
| 2012Q4 | -236661 USD | 633830 USD |
| 2012Q3 | -118900 USD | 318441 USD |
| 2012Q2 | 1.3 million USD | 595104 USD |
| 2012Q1 | -5.0 million USD | 618580 USD |
| 2011Q4 | 4.9 million USD | 604539 USD |
| 2011Q2 | ? USD | 995417 USD |
| 2011Q1 | ? USD | 1.2 million USD |
| 2010Q4 | ? USD | 1.2 million USD |
| 2010Q2 | ? USD | 3.1 million USD |
| 2010Q1 | ? USD | 4.1 million USD |
| 2009Q4 | ? USD | 4.0 million USD |
| 2009Q2 | ? USD | 3.4 million USD |
| 2009Q1 | ? USD | 2.8 million USD |
| 2008Q4 | ? USD | 2.0 million USD |
| 2008Q3 | -3.5 million USD | 2.3 million USD |
| 2008Q2 | -4.2 million USD | 2.8 million USD |
| 2008Q1 | -4.9 million USD | 3.2 million USD |
| 2007Q4 | -5.1 million USD | 3.0 million USD |
| 2007Q3 | -4.2 million USD | 3.0 million USD |
| 2007Q2 | -4.0 million USD | 2.9 million USD |
| 2007Q1 | -3.8 million USD | 2.8 million USD |
| 2006Q4 | -4.2 million USD | 4.1 million USD |
| 2006Q3 | -3.6 million USD | 1.8 million USD |
| 2006Q2 | -3.6 million USD | 1.8 million USD |
| 2006Q1 | -3.5 million USD | 1.7 million USD |
| 2005Q4 | -2.4 million USD | 3.2 million USD |
| 2005Q3 | -2.8 million USD | 5.5 million USD |
| 2005Q2 | -2.8 million USD | 5.5 million USD |
| 2005Q1 | -2.9 million USD | 2.3 million USD |
| 2004Q4 | -2.7 million USD | 3.6 million USD |
| 2004Q3 | -1.9 million USD | 3.5 million USD |
| 2004Q2 | -2.4 million USD | 3.2 million USD |
| 2004Q1 | -2.4 million USD | 3.1 million USD |
| 2003Q4 | -2.4 million USD | 3.1 million USD |
| 2003Q3 | -1.2 million USD | 13.0 million USD |
| 2003Q2 | -1.1 million USD | 12.7 million USD |
| 2003Q1 | -1.7 million USD | 3.0 million USD |
| 2002Q4 | -1.8 million USD | 2.8 million USD |
| 2002Q3 | -2.0 million USD | 2.7 million USD |
| 2002Q2 | -5.1 million USD | 7.0 million USD |
| 2002Q1 | -2.0 million USD | 2.6 million USD |
| 2001Q4 | -1.9 million USD | 2.5 million USD |
| 2001Q3 | -1.8 million USD | 2.4 million USD |
| 2001Q2 | -4.6 million USD | 6.3 million USD |
| 2001Q1 | -5.5 million USD | 7.5 million USD |
| 2000Q4 | -5.4 million USD | 7.5 million USD |
| 2000Q3 | -5.4 million USD | 7.5 million USD |
| 2000Q2 | 27.0 million USD | -1.3 million USD |
| 2000Q1 | -11.8 million USD | 5.8 million USD |
| 1999Q4 | -11.8 million USD | 5.8 million USD |
| 1999Q3 | -12.0 million USD | 5.9 million USD |
KZIA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -13.6 million USD | 368 USD |
| 2022 | -17.0 million USD | 17 USD |
| 2021 | -6.3 million USD | 11.4 million USD |
| 2020 | -8.6 million USD | 732 USD |
| 2019 | -7.2 million USD | 1096 USD |
| 2018 | -4.4 million USD | 9630 USD |
| 2017 | -8.2 million USD | 6.8 million USD |
| 2016 | -9.0 million USD | 3.0 million USD |
| 2015 | -5.5 million USD | 68339 USD |
| 2014 | -7.0 million USD | 81943 USD |
| 2013 | 1.2 million USD | 2.3 million USD |
| 2012 | 1.3 million USD | 1.5 million USD |
| 2011 | -6.9 million USD | 2.2 million USD |
| 2010 | -10.4 million USD | 8.3 million USD |
| 2009 | -15.3 million USD | 9.0 million USD |
| 2008 | -19.4 million USD | 12.7 million USD |
| 2007 | -17.0 million USD | 14.7 million USD |
| 2006 | -12.0 million USD | 10.0 million USD |
| 2005 | -9.5 million USD | 12.5 million USD |
| 2004 | -8.7 million USD | 11.4 million USD |
| 2003 | -7.0 million USD | 22.0 million USD |
| 2002 | -24.0 million USD | 33.2 million USD |
| 2001 | -21.6 million USD | 29.9 million USD |
| 2000 | -8.2 million USD | 16.1 million USD |
| 1999 | -11.2 million USD | 12.7 million USD |
KZIA
Price: $0.27
52 week price:
Earnings Per Share: -0.73 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 38900
Market Capitalization: 11.1 million